| Autor: |
Fondaj D; Department of Pharmacy-Pharmaceutical Sciences, University of Bari, 70125 Bari, Italy., Arduino I; Department of Pharmacy-Pharmaceutical Sciences, University of Bari, 70125 Bari, Italy., Lopedota AA; Department of Pharmacy-Pharmaceutical Sciences, University of Bari, 70125 Bari, Italy., Denora N; Department of Pharmacy-Pharmaceutical Sciences, University of Bari, 70125 Bari, Italy., Iacobazzi RM; Department of Pharmacy-Pharmaceutical Sciences, University of Bari, 70125 Bari, Italy. |
| Jazyk: |
angličtina |
| Zdroj: |
Pharmaceutics [Pharmaceutics] 2023 Jul 14; Vol. 15 (7). Date of Electronic Publication: 2023 Jul 14. |
| DOI: |
10.3390/pharmaceutics15071953 |
| Abstrakt: |
Nanomedicines have made remarkable advances in recent years, addressing the limitations of traditional therapy and treatment methods. Due to their improved drug solubility, stability, precise delivery, and ability to target specific sites, nanoparticle-based drug delivery systems have emerged as highly promising solutions. The successful interaction of nanoparticles with biological systems, on the other hand, is dependent on their intentional surface engineering. As a result, biomimetic nanoparticles have been developed as novel drug carriers. In-depth knowledge of various biomimetic nanoparticles, their applications, and the methods used for their formulation, with emphasis on the microfluidic production technique, is provided in this review. Microfluidics has emerged as one of the most promising approaches for precise control, high reproducibility, scalability, waste reduction, and faster production times in the preparation of biomimetic nanoparticles. Significant advancements in personalized medicine can be achieved by harnessing the benefits of biomimetic nanoparticles and leveraging microfluidic technology, offering enhanced functionality and biocompatibility. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
|
Nepřihlášeným uživatelům se plný text nezobrazuje |
K zobrazení výsledku je třeba se přihlásit.
|
